AAAAAA

   
Results: 1-17 |
Results: 17

Authors: KOBAYASHI J TASHIRO J MURANO S MORISAKI N SAITO Y
Citation: J. Kobayashi et al., LIPOPROTEIN-LIPASE MASS AND ACTIVITY IN POSTHEPARIN PLASMA FROM SUBJECTS WITH INTRAABDOMINAL VISCERAL FAT ACCUMULATION, Clinical endocrinology, 48(4), 1998, pp. 515-520

Authors: TASHIRO J TAKAHASHI K YOKOTE K TAKAHASHI M INADERA H KOBAYASHI J KANZAKI T MURANO S SHINOMIYA M MORISAKI N SAITO Y
Citation: J. Tashiro et al., ADMINISTRATION OF A SMALL AMOUNT OF LARD ENHANCES INTIMAL THICKENING IN THE BALLOON CATHETER INJURY MODEL WITHOUT AFFECTING SERUM-LIPIDS, Scandinavian journal of clinical & laboratory investigation, 58(2), 1998, pp. 149-154

Authors: TASHIRO J ENDO M BUJO H SHINOMIYA M MORISAKI N SAITO Y
Citation: J. Tashiro et al., NEW-TYPE OF THE INTERNALIZATION-DEFECTIVE LOW-DENSITY-LIPOPROTEIN RECEPTOR OWING TO 2-NUCLEOTIDE DELETION (2199DELCA OR 2201DELCA) IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, European journal of clinical investigation, 28(9), 1998, pp. 712-719

Authors: TANNER F TASHIRO J BOHM M DUCKERS E GORDON D NABEL GJ NABEL EG
Citation: F. Tanner et al., CKIS AND CONTROL OF VASCULAR SMOOTH-MUSCLE CELL-CYCLE, The FASEB journal, 11(9), 1997, pp. 830-830

Authors: KOBAYASHI J YAMAZAKI K TASHIRO J MURANO S SAITO Y MORISAKI N
Citation: J. Kobayashi et al., TYPE-III HYPERLIPIDEMIA WITH PRIMARY HYPOTHYROIDISM - A UNIQUE CLINICAL COURSE OF HYPERLIPIDEMIA DURING REPLACEMENT THERAPY OF THYROID-HORMONE, Clinical endocrinology, 46(5), 1997, pp. 627-630

Authors: TANNER F TASHIRO J BOHM M DUCKERS E GORDON D NABEL GJ NABEL EG
Citation: F. Tanner et al., CKIS AND CONTROL OF VASCULAR SMOOTH-MUSCLE CELL-CYCLE, Atherosclerosis, 134(1-2), 1997, pp. 109-109

Authors: MORISAKI N SAITO I TAMURA K TASHIRO J MASUDA M KANZAKI T WATANABE S MASUDA Y SAITO Y
Citation: N. Morisaki et al., NEW INDEXES OF ISCHEMIC-HEART-DISEASE AND AGING - STUDIES ON THE SERUM LEVELS OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) AND SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND ISCHEMIC-HEART-DISEASE, Atherosclerosis, 131(1), 1997, pp. 43-48

Authors: NAKAMURA H OHASHI Y MARUHAMA Y NINOMIYA K TOYOTA T OIKAWA S SEKIKAWA A HAYASAKA K MIDORIKAWA H YAMASHITA K MATSUSHIMA T KAWAKAMI M SAKURABAYASHI L ISHIKAWA T SAITO Y MORISAKI N TASHIRO J KANZAKI T MASUDA M KAMIMATSUSE K FUJIOKA T TOCHIHARA T YAGI H SUGIMOTO K YAMANAKA M TERAMOTO T KINOSHITA M KUROKAWA K HASHIMOTO Y HORIE Y YAZAKI Y YAMADA N ISHIBASHI S ITAKURA H ORIMO H OUCHI Y NAKAMURA S KAWAMURA M HANDA S TAMACHI H SHIINA Y HOMMA Y FUJINAMI T MABUCHI H KOIZUMI J KAJINAMI K KITA T YOKODE M MATSUZAWA Y TAKEMURA K YAMAMOTO A YAMAMURA T TSUSHIMA M YOKOYAMA M TANIGUCHI T KAJIYAMA G HAYASHI K ARAKAWA K SAKU K
Citation: H. Nakamura et al., EFFICACY OF ATORVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA, The American journal of cardiology, 79(9), 1997, pp. 1248

Authors: TASHIRO J NAGASHIMA I OTABE M TAMURA K MASUDA M SAITO I KANZAKI T MURANO S MORISAKI N SAITO Y
Citation: J. Tashiro et al., SIGNIFICANCE OF A POLYMORPHISM (G-A TRANSITION) IN THE -78 POSITION OF THE APOLIPOPROTEIN-A-I GENE PROMOTER IN PATIENTS WITH ELEVATED SERUMHDL CHOLESTEROL LEVELS IN JAPANESE, Circulation, 94(8), 1996, pp. 1593-1593

Authors: YOSHIDA S MURANO S SAITO Y INADERA H TASHIRO J KOBAYASHI J TADOKORO N KANZAKI T SHINOMIYA M MORISAKI N OHONO K ISHIKAWA Y SHIRAI K AZUMA Y KODAMA K
Citation: S. Yoshida et al., TREATMENT OF OBESITY BY PERSONALITY CLASSIFICATION-ORIENTED PROGRAM, Obesity research, 3, 1995, pp. 205-209

Authors: SHINOMIYA M TASHIRO J SAITO Y YOSHIDA S FURUYA M OKA N TANAKA S KANGAWA K MATSUO H
Citation: M. Shinomiya et al., C-TYPE NATRIURETIC PEPTIDE INHIBITS INTIMAL THICKENING OF RABBIT CAROTID-ARTERY AFTER BALLOON CATHETER INJURY, Biochemical and biophysical research communications, 205(2), 1994, pp. 1051-1056

Authors: KOBAYASHI J TAKAHASHI K TASHIRO J SHIRAI K SAITO Y YOSHIDA S HASHIMOTO H FUKAMACHI I NIIHARA K SASAKI N
Citation: J. Kobayashi et al., EFFECTS OF TREATMENT WITH BEZAFIBRATE ON LIPOPROTEIN-LIPASE ACTIVITY AND MASS IN PATIENTS WITH HYPERTRIGLYCERIDEMIA, Arzneimittel-Forschung, 44-1(2), 1994, pp. 145-148

Authors: MORISAKI N YOKOTE K TASHIRO J INADERA H KOBAYASHI J KANZAKI T SAITO Y YOSHIDA S
Citation: N. Morisaki et al., LIPOPROTEIN(A) IS A RISK FACTOR FOR DIABETIC-RETINOPATHY IN THE ELDERLY, Journal of the American Geriatrics Society, 42(9), 1994, pp. 965-967

Authors: MORISAKI N WATANABE S KOBAYASHI J KANZAKI T TAKAHASHI K YOKOTE K TEZUKA M TASHIRO J INADERA H SAITO Y YOSHIDA S SHIGEMURA K
Citation: N. Morisaki et al., DIABETIC CONTROL AND PROGRESSION OF RETINOPATHY IN ELDERLY PATIENTS -5-YEAR FOLLOW-UP-STUDY, Journal of the American Geriatrics Society, 42(2), 1994, pp. 142-145

Authors: TASHIRO J NISHIDE T SHINOMIYA M SHIRAI K SAITO Y YOSHIDA S YAMASHITA M OHSHIMA H MURAYAMA H
Citation: J. Tashiro et al., THE MIDBAND LIPOPROTEIN IS A CORONARY RISK FACTOR IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Scandinavian journal of clinical & laboratory investigation, 53(4), 1993, pp. 335-338

Authors: SHINOMIYA M NISHIDE T TASHIRO J SHIRAI K SAITO Y YOSHIDA S
Citation: M. Shinomiya et al., EFFECT OF 5-YEAR ADMINISTRATION OF PROBUCOL ON DEVELOPMENT OF MYOCARDIAL-INFARCTION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Current therapeutic research, 54(2), 1993, pp. 142-151

Authors: KOBAYASHI J HASHIMOTO H FUKAMACHI I TASHIRO J SHIRAI K SAITO Y YOSHIDA S
Citation: J. Kobayashi et al., LIPOPROTEIN-LIPASE MASS AND ACTIVITY IN SEVERE HYPERTRIGLYCERIDEMIA, Clinica chimica acta, 216(1-2), 1993, pp. 113-123
Risultati: 1-17 |